• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区药房丙型肝炎筛查项目的可行性及结果

Feasibility and outcomes of a hepatitis C screening programme in community pharmacies.

作者信息

Gauld Natalie, Perry John, Jackson Catherine, Gane Ed

机构信息

Natalie Gauld Ltd, Auckland; Senior Honorary Research Fellow, Department of Paediatrics Child and Youth Health, The University of Auckland.

Gastroenterology, Waitematā District Health Board, Auckland.

出版信息

N Z Med J. 2020 Nov 20;133(1525):74-83.

PMID:33223550
Abstract

AIMS

To ascertain the feasibility and outcomes of point-of-care testing for hepatitis C virus (HCV) antibodies in people with risk factors screened in community pharmacies.

METHODS

Ten pharmacies in the Waitematā District Health Board piloted point-of-care antibody HCV screening with consenting participants. Individuals with a positive HCV antibody result had a confirmatory HCV RNA test performed at a local laboratory, with pharmacist follow-up to discuss the result. RNA positive individuals were referred to their general practitioner for further follow-up including antiviral therapy. Number of tests, number of positives and number treated were collected. Pharmacists completed a survey about their experiences.

RESULTS

Of 192 participants, seven (3.6%) had positive tests on screening, four of whom had a positive RNA assay and received HCV medication, and one of whom had a positive RNA assay but has not yet received treatment. Two had negative RNA results. Pharmacist feedback was very positive with most wishing to continue the point-of-care testing service. Most wanted to be able to treat HCV in order to improve linkage to care.

CONCLUSIONS

Pharmacy point-of-care testing with immediate results and pharmacist follow-up of positive results can aid diagnosis of HCV in at-risk populations and help treatment uptake.

摘要

目的

确定在社区药房对有风险因素的人群进行丙型肝炎病毒(HCV)抗体即时检测的可行性和结果。

方法

怀塔玛塔地区卫生委员会的10家药房对同意参与的参与者进行了HCV抗体即时检测试点。HCV抗体检测结果呈阳性的个体在当地实验室进行了HCV RNA确认检测,药剂师进行随访以讨论检测结果。RNA检测呈阳性的个体被转介给他们的全科医生进行进一步随访,包括抗病毒治疗。收集了检测数量、阳性数量和接受治疗的数量。药剂师完成了一项关于他们经历的调查。

结果

在192名参与者中,7人(3.6%)筛查检测呈阳性,其中4人RNA检测呈阳性并接受了HCV治疗,1人RNA检测呈阳性但尚未接受治疗。2人RNA检测结果为阴性。药剂师的反馈非常积极,大多数人希望继续提供即时检测服务。大多数人希望能够治疗HCV,以改善与治疗的衔接。

结论

药房即时检测并即时出结果,以及药剂师对阳性结果进行随访,有助于对高危人群进行HCV诊断并促进治疗。

相似文献

1
Feasibility and outcomes of a hepatitis C screening programme in community pharmacies.社区药房丙型肝炎筛查项目的可行性及结果
N Z Med J. 2020 Nov 20;133(1525):74-83.
2
Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.药剂师在社区药房开展丙型肝炎病毒筛查,以提高认知度并与医疗中心的护理建立联系。
J Am Pharm Assoc (2003). 2017 May-Jun;57(3S):S259-S264. doi: 10.1016/j.japh.2017.03.006.
3
Patient awareness, willingness, and barriers to point-of-care hepatitis C screening in community pharmacy.社区药房即时丙肝筛查中患者的认知、意愿及障碍
J Am Pharm Assoc (2003). 2018 Jul-Aug;58(4S):S69-S72.e1. doi: 10.1016/j.japh.2018.04.031.
4
Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project.药剂师在社区药房开展丙型肝炎抗体即时检测筛查:一项试点项目。
J Am Pharm Assoc (2003). 2017 Jul-Aug;57(4):510-515.e2. doi: 10.1016/j.japh.2017.04.463. Epub 2017 Jun 9.
5
Innovating the Model for Student Pharmacists to Increase Access to Hepatitis C Testing (Project IMPACT).创新学生药剂师模式以增加丙型肝炎检测可及性(“影响”项目)
J Am Pharm Assoc (2003). 2023 Jul-Aug;63(4):1217-1221. doi: 10.1016/j.japh.2023.04.001. Epub 2023 Apr 8.
6
Pharmacist Comfort and Awareness of HIV and HCV Point-of-Care Testing in Community Settings.药剂师对社区环境中艾滋病毒和丙型肝炎即时检测的舒适度与认知度
Health Promot Pract. 2020 Sep;21(5):831-837. doi: 10.1177/1524839919857969. Epub 2019 Jul 1.
7
Hepatitis C virus screening in community pharmacies: results on feasibility from a Swiss pilot.社区药店丙型肝炎病毒筛查:瑞士试点可行性研究结果。
BMC Infect Dis. 2023 Jun 7;23(1):384. doi: 10.1186/s12879-023-08362-1.
8
Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.药师主导与常规提供的抗病毒治疗在接受阿片类药物替代治疗的丙型肝炎病毒患者中的临床效果:一项实用的、集群随机试验。
Lancet Gastroenterol Hepatol. 2020 Sep;5(9):809-818. doi: 10.1016/S2468-1253(20)30120-5. Epub 2020 Jun 8.
9
DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy.DOT-C:一项在社区药房接受阿片类药物替代治疗的人群中评估直接观察抗 HCV 治疗的整群随机可行性试验。
Int J Drug Policy. 2017 Sep;47:126-136. doi: 10.1016/j.drugpo.2017.05.042. Epub 2017 Jun 21.
10
Time and motion study of hepatitis C virus point-of-care testing in community pharmacies.社区药房丙型肝炎病毒即时检测的时间与动作研究
J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):435-439. doi: 10.1016/j.japh.2022.11.002. Epub 2022 Nov 5.

引用本文的文献

1
Experiences of people who inject drugs with hepatitis C testing and their perceptions of a pharmacy-based testing option: a qualitative study.注射吸毒者进行丙型肝炎检测的经历及其对基于药房的检测选项的看法:一项定性研究。
Int J Clin Pharm. 2025 Aug 29. doi: 10.1007/s11096-025-01986-0.
2
Hepatitis C Screening in Community Pharmacies-A Feasibility and Knowledge Transfer Study: PHARMA-C.社区药房的丙型肝炎筛查——一项可行性与知识转移研究:PHARMA-C
J Assoc Med Microbiol Infect Dis Can. 2024 Oct 25;9(3):161-172. doi: 10.3138/jammi-2024-0010. eCollection 2024 Oct.
3
Viral hepatitis testing and treatment in community pharmacies: a systematic review and meta-analysis.
社区药房中的病毒性肝炎检测与治疗:一项系统综述和荟萃分析
EClinicalMedicine. 2024 Feb 27;69:102489. doi: 10.1016/j.eclinm.2024.102489. eCollection 2024 Mar.
4
Telemedicine Chronic Viral Hepatitis C Treatment during the Lockdown Period in Romania: A Pilot Study.罗马尼亚封锁期间的远程医疗慢性丙型肝炎治疗:一项试点研究。
Int J Environ Res Public Health. 2021 Apr 1;18(7):3694. doi: 10.3390/ijerph18073694.